Is Lantheus Holdings, Inc. overvalued or undervalued?

As of 17 October 2025, Lantheus Holdings, Inc. has moved from fair to attractive in its valuation grade. The company appears to be undervalued, with a P/E ratio of 15, an EV to EBITDA of 10.33, and an impressive ROCE of 56.47%. In comparison, QIAGEN NV has a P/E of 24.20, indicating that Lantheus is trading at a significant discount relative to some of its peers.
Additionally, while Lantheus has shown strong performance in the past five years with a return of 316.48%, it has struggled recently, with a year-to-date return of -37.85%, compared to the S&P 500's 13.30%. This stark contrast highlights the potential for recovery and growth in Lantheus's valuation moving forward.